Arcutis Biotherapeutics Quote - ARQT

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

15.11

Bid

13.25

Offer

17.30

Volume

5,216,399

14.11 Day's Range 15.79

2.45 52 Week Range 15.20

Market Cap

1.769B

Previous Close

14.11

Open

14.11

Last Trade

15.2

Last Trade Time

Financial Volume

US$ 79,417,067

VWAP

15.2245

Average Volume (3m)

2,001,429

Shares Outstanding

117,044,591

Dividend Yield

PE Ratio

-6.70

Earnings Per Share (EPS)

-2.24

Revenue

59.61M

Net Profit

-262.14M

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targe... Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate, roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.arcutis.com

Headquarters

Wilmington, Delaware, USA

Founded

Arcutis Biotherapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ARQT. The last closing price for Arcutis Biotherapeutics was US$14.11. Over the last year, Arcutis Biotherapeutics shares have traded in a share price range of US$ 2.45 to US$ 15.20.

Arcutis Biotherapeutics currently has 117,044,591 shares in issue. The market capitalisation of Arcutis Biotherapeutics is US$1.65 billion. Arcutis Biotherapeutics has a price to earnings ratio (PE ratio) of -6.70.

Overall Flow

Bullish

Net Premium

695k

Calls / Puts

350.00%

Buys / Sells

80.00%

OTM / ITM

200.00%

Sweeps Ratio

0.00%

Form 144 - Report of proposed sale of securities

Arcutis Submits ZORYVE® (roflumilast) Cream 0.05% Supplemental New Drug Application to the FDA for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis

ZORYVE cream 0.05% provided meaningful disease clearance and rapid reduction in itch in pivotal trialsRoflumilast cream was well tolerated and demonstrated a favorable safety and tolerability...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	2.925	24.004924087	12.185	15.2	12.185	2684424	13.84641236	CS
4	4.88	47.7028347996	10.23	15.2	10.06	2074701	12.74918677	CS
12	5.86	63.3513513514	9.25	15.2	8.03	2001429	10.61422987	CS
26	7.01	86.5432098765	8.1	15.2	7.89	2217814	10.08690442	CS
52	12.58	497.233201581	2.53	15.2	2.45	3216277	8.43770417	CS
156	-1.69	-10.0595238095	16.8	27.4	1.76	1816293	8.91057969	CS
260	-7.94	-34.4468546638	23.05	40.88	1.76	1182436	10.05248121	CS

ARQT - Frequently Asked Questions (FAQ)

What is the current Arcutis Biotherapeutics share price?

The current share price of Arcutis Biotherapeutics is US$ 15.11

How many Arcutis Biotherapeutics shares are in issue?

Arcutis Biotherapeutics has 117,044,591 shares in issue

What is the market cap of Arcutis Biotherapeutics?

The market capitalisation of Arcutis Biotherapeutics is USD 1.65B

What is the 1 year trading range for Arcutis Biotherapeutics share price?

Arcutis Biotherapeutics has traded in the range of US$ 2.45 to US$ 15.20 during the past year

What is the PE ratio of Arcutis Biotherapeutics?

The price to earnings ratio of Arcutis Biotherapeutics is -6.7

What is the cash to sales ratio of Arcutis Biotherapeutics?

The cash to sales ratio of Arcutis Biotherapeutics is 29.47

What is the reporting currency for Arcutis Biotherapeutics?

Arcutis Biotherapeutics reports financial results in USD

What is the latest annual turnover for Arcutis Biotherapeutics?

The latest annual turnover of Arcutis Biotherapeutics is USD 59.61M

What is the latest annual profit for Arcutis Biotherapeutics?

The latest annual profit of Arcutis Biotherapeutics is USD -262.14M

What is the registered address of Arcutis Biotherapeutics?

The registered address for Arcutis Biotherapeutics is 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, NEW CASTLE, WILMINGTON, DELAWARE, 19810

What is the Arcutis Biotherapeutics website address?

The website address for Arcutis Biotherapeutics is www.arcutis.com

Which industry sector does Arcutis Biotherapeutics operate in?

Arcutis Biotherapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MYSZMy Size Inc	US$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.5M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.63M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.84M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	8.58M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	5.96M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	281.23M